Retrozin Sustained Release Tablet (Levodropropizine)

Adult dosage

Adults: Take 1 tablet per dose (equivalent to 90mg of levodropropizine) orally twice daily. This is an extended-release formulation; swallow it whole without splitting or crushing it.

This medication should not be used by individuals who are allergic to this drug or any of its ingredients. It is not safe to administer to patients with excessive bronchial mucus secretion or those with impaired mucociliary function. Women who are pregnant, may become pregnant, or are breastfeeding should not use this medication. Patients with severely impaired liver function should also avoid taking this drug. This medication contains lactose, so individuals with lactose intolerance or certain genetic conditions should refrain from taking it. Patients with severely compromised heart function, severely reduced kidney function, elderly patients, and children should use this medication with caution. During treatment, gastrointestinal symptoms such as nausea, dyspepsia, and constipation may occur occasionally, as well as central nervous system reactions such as drowsiness, headache, and dizziness. Additionally, some patients have reported adverse reactions such as eyelid swelling or increased leukocytes in urine. Caution is required when driving or operating machinery as drowsiness or a semi-conscious state may occur, and these symptoms may be exacerbated when taken with alcohol. Because this is a sustained release formulation, alternative formulations that allow for dose division should be used for children. Patients using sedatives should be particularly cautious, as they may be more sensitive to the effects of this medication. This medication should be stored out of reach of children, and care should be taken not to alter its quality by transferring it to another container.

• Nausea
• dyspepsia
• constipation
• drowsiness
• headache
• dizziness
• positional vertigo
• eyelid swelling
• increased urinary leucocytes
• elevated ALT

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance

A rectangular sustained release tablet consisting of a white to light yellow upper layer and a white lower layer.

Package unit

30 tablets/bottle, 300 tablets/bottle